Legend Biotech Corp Adr stock is traded at $22.54, with a volume of 3,232,593. It is down -1.01% in the last 24 hours and up +20.41% over the past month. Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Previous Close:
$22.77
Open:
$22.77
24h Volume:
3,232,593
Relative Volume:
1.50
Market Cap:
$4.38B
Revenue:
$1.14B
Net Income/Loss:
-$250.98M
P/E Ratio:
-
EPS:
-$1.36
Net Cash Flow:
-$251.61M
1W Performance:
+4.21%
1M Performance:
+20.41%
6M Performance:
-22.17%
1Y Performance:
-30.37%
1-Day Range:
$0.00$0.00
1-Week Range:
$20.99$23.98
52-Week Range:
$16.24$37.50
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS